Part I. Infantile Hemangioma: Literature review of current science, classification and management
| Autor: | Msiii Alexander C. Schlarb, Andrew S. Martin, Ronald J. Zagoria, Timothy A. VanHoose |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Abdominal pain medicine.diagnostic_test business.industry Hepatic capsule Computed tomography Diagnostic dilemma medicine.disease medicine.disease_cause Gastroenterology Fitz-Hugh–Curtis syndrome Capsulitis Internal medicine Pelvic inflammatory disease medicine medicine.symptom Chlamydia trachomatis business |
| Zdroj: | West Virginia Medical Journal. 115:12-15 |
| DOI: | 10.21885/wvmj.2019.1 |
| Popis: | Infantile hemangioma is the most common benign tumor in infants. These vascular tumors are not usually present at birth but will begin to form within the first 12 weeks after birth, completing growth by 9-12 months of age, then entering into an involutional stage of several years. Tumors vary from very small, non-invasive to large tumors that cause disfigurement and depending upon location, functional compromise. Hemangiomas may not entirely resolve, often times leaving residual tumor or a lipo- fibrotic mass with dermal scarring. Treatment for hemangiomas is varied and may include, but not limited to, observation, surgery, corticosteroids, beta-blockers, and laser therapy. Choice of treatment is based on size, location, and stage of tumor growth. This review article is presented in two parts: Part I- a comprehensive literature review of the current science of the biology of hemangioma formation, classification schemes, and management. Part II follows with our institutional review of the management of these sometimes challenging lesions of childhood. (Part I will be published in the 2nd Quarter edition of the WVMJ.) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|